Malta

Malta has solidified its reputation as a premier life sciences hub in the Mediterranean, offering a sophisticated ecosystem that integrates pharmaceutical manufacturing, biotechnology and cutting-edge healthcare innovation.

Best known for its robust regulatory framework and strategic location, the island is a primary destination for EU-standard GMP manufacturing, particularly in the production of high-quality generic medicines and specialized pharmaceuticals.

The Malta Life Sciences Park (MLSP) serves as the nation’s focal point for biotechnology research, providing world-class laboratory facilities that foster collaboration between startups and established international firms.

In the medical device sector, Malta is recognized for advanced precision engineering and the development of innovative diagnostic tools, supported by a workforce skilled in medtech assembly and regulatory compliance.

The island’s healthcare innovation landscape is further enriched by its "test-bed" status, where digital health solutions and AI-driven medical technologies are piloted within a modern national health system.

Academic research in Malta, led by the University of Malta, excels in genomics and personalized medicine, bridging the gap between clinical discovery and commercial application.

Investors are drawn to Malta’s R&I tax credits, which offer a 175% deduction on eligible expenditures, alongside a competitive fiscal environment for intellectual property.

As a member of the European Union, Malta provides seamless market access to the Single Market, making it a strategic gateway for life science companies targeting EMEA regions.

This synergistic blend of contract manufacturing (CMO) excellence, R&D incentives and a bio-entrepreneurial community positions Malta as a leading contender on the global life sciences stage.